Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Rectal Neoplasms × Enzyme-Linked Immunosorbent Assay × Clear all

Sponsor

Conditions

Breast Neoplasms 3 Prostatic Neoplasms 2 Breast Neoplasms, Male 2 Waldenstrom Macroglobulinemia 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sezary Syndrome 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Myeloproliferative Disorders 1 Mycosis Fungoides 1 Multiple Myeloma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Myeloid, Acute 1 Leukemia, Mast-Cell 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Biphenotypic, Acute 1 Intraocular Lymphoma 1 Immunoblastic Lymphadenopathy 1 Hodgkin Disease 1

Interventions

Oxaliplatin 46 Fluorouracil 43 Leucovorin 40 Capecitabine 36 Bevacizumab 28 Irinotecan 27 Radiotherapy 22 Cetuximab 21 Panitumumab 12 Radiation 11 Folfox protocol 10 Surgical Procedures, Operative 9 IFL protocol 7 Radiotherapy, Intensity-Modulated 6 aflibercept 5 Magnetic Resonance Spectroscopy 5 Immunohistochemistry 5 Chemotherapy, Adjuvant 5 Gene Expression Profiling 4 Floxuridine 4 dehydroftorafur 3 XELOX 3 Ramucirumab 3 Neoadjuvant Therapy 3 Fluorodeoxyglucose F18 3 Erlotinib Hydrochloride 3 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 3 veliparib 2 trifluridine tipiracil drug combination 2 regorafenib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡